Abstract
Human CAP (CEVEC’s Amniocyte Production) cells allow for stable production of recombinant proteins with excellent biologic activity and therapeutic efficacy as a result of authentic posttranslational modification. Based on human CAP cells a new transient expression system has been developed, that is scalable and serum-free and enables extremely high production yields of recombinant proteins within a few days. The novel CAP-T transient human cell expression system is a rapid and versatile tool for fast and serum-free protein expression for screening, assay development, drug discovery and early stage pre-clinical drug development. From gene to mg amounts within two weeks – fast process times and high yields even for highly glycosylated proteins are key feature of the CAP-T expression system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this paper
Cite this paper
Bialek, C., Hertel, S., Scholz-Neumann, N., Essers, R., Schiedner, G. (2012). Very High Protein Production Levels with a New Transient and Serum-Free Expression System Based on Human CAP Cells. In: Jenkins, N., Barron, N., Alves, P. (eds) Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. ESACT Proceedings, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0884-6_80
Download citation
DOI: https://doi.org/10.1007/978-94-007-0884-6_80
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0883-9
Online ISBN: 978-94-007-0884-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)